Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1729 of 6351
-
New hope for drug-resistant GIST: combo therapy targets stubborn tumors
Disease control OngoingThis is an open label, single arm, phase 2 trial investigating bezuclastinib plus sunitinib in patients with GIST who have previously progressed on sunitinib.
Phase 2 • Sponsor: Sarcoma Alliance for Research through Collaboration • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Ginseng vs. fatigue: major trial tests natural remedy for cancer patients
Symptom relief Recruiting nowThis phase III trial compares the effect of Wisconsin ginseng (panax quinquefolius) to placebo in patients with cancer that suffer from significant fatigue. Fatigue is among the most challenging symptoms to manage in patients with cancer, both on or off active treatment. This sym…
Phase 3 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
New combo therapy aims to shrink deadly esophageal tumors
Disease control Recruiting nowThe goal of this clinical trial is to investigate the safety and efficacy of a new treatment approach for T4-stage esophageal cancer, which involves chemoradiotherapy after induction chemotherapy. The main questions it aims to answer are: * Does the new induction chemotherapy fo…
Phase 1/2 • Sponsor: National Cheng-Kung University Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New heart procedure could replace pacemakers for fainting patients
Disease control Recruiting nowThe CNA-FWRD Registry is an international prospective observational multicenter registry of patients with symptomatic vasovagal syncope and bradyarrhythmias managed under routine care by medical therapy and radiofrequency catheter ablation of ganglionated plexi or permanent pacem…
Sponsor: Rush University Medical Center • Aim: Disease control
Last updated Jun 26, 2026 17:46 UTC
-
New hope for rare cancers: drug combo trial launches
Disease control Recruiting nowBackground: Rare tumors of the genitourinary (GU) tract can appear in the kidney, bladder, ureters, and penis. Rare tumors are difficult to study because there are not enough people to conduct large trials for new treatments. Two drugs-sacituzumab govitecan (SG) and atezolizumab…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New drug helps prevent bleeds in toddlers with hemophilia
Disease control CompletedHemophilia A (HA) is a rare congenital bleeding disorder characterized by coagulation factor VIII deficiency. In severe HA, defined as plasma FVIII clotting activity \< 1%, bleeding may frequently occur spontaneously, most commonly in joints, leading to painful hemophilic arthrop…
Sponsor: Montefiore Medical Center • Aim: Disease control
Last updated Jun 26, 2026 14:49 UTC
-
Can a smart app help you save a life? new trial aims to boost CPR quality
Disease control Recruiting nowThe rise in out-of-hospital cardiac arrest (OHCA) cases in Singapore highlights the need for effective bystander cardiopulmonary resuscitation (BCPR). Despite many lay responders performing CPR, survival rates with good neurological outcomes have not significantly improved, promp…
Sponsor: Singapore General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
AI tool spots pneumonia risk after brain surgery
Diagnosis CompletedPostoperative pneumonia (POP) is a common and serious complication after elective craniotomy for brain tumor resection. POP often develops within the first week after surgery and may lead to prolonged hospitalization, higher medical costs, and increased risk of severe illness. Be…
Sponsor: Ming Yang • Aim: Diagnosis
Last updated Jun 27, 2026 08:09 UTC
-
New injection shows promise for dangerous fat levels
Disease control CompletedDR10624 is an Fc fusion protein tri-agonist with balanced glucagon-like peptide-1 receptor (GLP-1R)/glucagon receptor (GCGR)/ fibroblast growth factor 21 receptor (FGF21R) agonizing activities. The objectives of the planned clinical investigation will be to evaluate the efficacy …
Phase 2 • Sponsor: Zhejiang Doer Biologics Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New hope for myelofibrosis patients: tasquinimod trial launches
Disease control Recruiting nowTo learn if tasquinimod either alone or in combination with ruxolitinib can help to control PMF, post-PV MF, or post-ET MF.
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Breath and blood may reveal hidden cancer early
Diagnosis Recruiting nowThe goal of this minimally invasive interventional study is to learn if oncometabolic biomarkers, detected in the exhaled breath and blood can identify early-stage gastro-oesophageal cancer in patient at risk for gastro-oesophageal cancer. The main questions this study aims to a…
Sponsor: KU Leuven • Aim: Diagnosis
Last updated Jun 27, 2026 09:05 UTC
-
Can a single drug ease Crohn's gut blockages?
Disease control Recruiting nowThis study intends to select patients with confirmed moderate-to-severe Crohn's disease (CD) and obstructive symptoms of intestinal stenosis, who have clear evidence of lumen stenosis caused by the disease itself through radiography or endoscopy. After the informed consent of the…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Can a cancer drug sharpen the mind and hands in advanced MS?
Disease control Recruiting nowThe goal of this clinical trial is to know if rituximab can improve cognitive and hand functions in secondary progressive multiple sclerosis (SPMS) patients with high disability (EDSS 6.5 or more). The main questions it aims to answer are: Can rituximab improve cognitive and han…
Phase 2 • Sponsor: Cairo University • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Glowing poop test could spot rare infant liver disease
Diagnosis Recruiting nowBiliary atresia is a rare, progressive liver disease that only affects infants. It leads to complete obstruction and scarring of the bile duct. Current non-invasive diagnostic tests have limited sensitivity. Indocyanine Green (ICG) is a non-radioactive, fluorescent compound with…
Phase 1/2 • Sponsor: Boston Children's Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:04 UTC
-
Can better coordination save lives? VA tests intensive case management for veterans at risk of suicide
Symptom relief Recruiting nowThe goal of this randomized clinical trial is to build the evidence base for SUPERCEDE, a suicide prevention focused intensive case management intervention to increase access, improve care coordination, provide suicide prevention monitoring, and procure a timely response of VA me…
Sponsor: VA Eastern Colorado Health Care System • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Can magnetic pulses help stroke survivors speak again?
Symptom relief Recruiting nowThe goal of this clinical trial is to determine if Transcranial Magnetic Stimulation (TMS) combined with modified Constraint Induced Language Therapy (mCILT) is an effective treatment for aphasia when delivered in the subacute stage after stroke. The main questions this study ai…
Phase 2 • Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Could immune cells in fat hold the key to Obesity-Related disease?
Knowledge-focused Recruiting nowThe goal of this study is to evaluate the role of transcription factor EB (TFEB) in adipose (fat) tissue macrophages (ATM) in regulating adipose tissue and systemic metabolic function in obesity. The investigators will assess the differences in ATM lipid metabolism in people with…
Sponsor: Bettina Mittendorfer • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
A good Night's sleep: could a simple program ease Cancer's toll on rest?
Symptom relief Recruiting nowThe purpose of this study is to learn about sleep behaviors and test different ways to help patients with cancer and partners. Participants (patient-sleep-partner caregivers dyads as a unit) participate in the study together.
Sponsor: University of Miami • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
Could a smart glucose meter transform diabetes care?
Disease control Recruiting nowThe study aims to evaluate the impact of a telemonitoring system on glycemic control in patients with diabetes in Tunisia. Participants in the intervention group will receive remote diabetes management through a dedicated mobile application and web platform, while the control gro…
Sponsor: University of Monastir • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Mindfulness may be the Athlete's secret weapon for faster recovery
Knowledge-focused CompletedThis randomized, counterbalanced crossover study investigated whether a mindfulness induction could improve kicking performance and facilitate psychophysiological recovery following fatigue manipulation in taekwondo athletes. After completing a cognitively demanding task and a si…
Sponsor: National Taiwan Normal University • Aim: Knowledge-focused
Last updated Aug 22, 2026 00:00 UTC